618-36-0 | Sigma-Aldrich

Product Information Sheet - F6771

Pharmacopoeia, 31st ed., Reynolds, J. E. F., ed., Royal Pharmaceutical Society (London, UK: 1996), p. 618. 3. Keezer, S. M., et al., Angiogenesis inhibitors target the endothelial cell cytoskeleton through

Rappaport Vassiliadis Medium

products by using Rappaport-Vassiliadis-(RV)- enrichment broth. Appl. Environm. Microbiol. 42: 615-618. Ordering Information Product Cat. No. Pack size Other packaging Size Rappaport Vassiliadis

Data Sheet 1.46767

Media for Food and Water Microbiology. (Corry, J.E.L., Curtis, G.D.W. and Baird, R.M. eds)., pp. 605-618. Royal Society of Chemistry, Cambridge, UK. Ordering Information Product Cat. No. Pack size

JULABO Catalog 2011 en

0.23-0.45 23 x 14 / 20 16 36 x 46 x 69 9 153 634 F34-MA -30 ... +150 ±0.02 2 0.45 0.32 0.14 0.03 -- 11-16 0.23-0.45 24 x 30

User Guide- SCR550,SCR703,SCR714,SCR549

pluripotency and direct differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7(5):618-630. 3. Yoshioka, N., et. al. (2013). Efficient Generation of human iPSCs by a synthetic self-replicative

User Guide-SCR714M

pluripotency and direct differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7(5):618-630. 3. Yoshioka, N., et. al. (2013). Efficient Generation of human iPSCs by a synthetic self-replicative

LIGHT DIAGNOSTICS SimulFluor RSV/PARA 3 DFA KIT multi language

MONOCLONALES: VRS Para3 Positivo verdadero 66 28 Positivo falso 0 0 Negativo verdadero 580 618 Negativo falso 0 0 Sensibilidad relativa (%) 100 100 Especificidad relativa (%) 100 100 Valor

BRAND Katalog EN

Subdivisions °Bé Length approx. mm Cat. No. 0 - 35 1 250 9715 28 0 - 50 1 250 9715 34 0 - 70 1 250 9715 35

Neuroscience Product Selection Guide

46-608 MILLIPLEX® map Total IRS1 MAPmate™ 46-628 MILLIPLEX® map Total JNK/SAPK1 MAPmate™ 46-618 MILLIPLEX® map Total STAT3 MAPmate™ 46-625 MILLIPLEX® map Phospho STAT6 (Tyr641) MAPmate™ 46-

Brochure: Chromolith® Monolithic Silica HPLC Columns for small and large molecule separation

Time %A %B 0 100 0 1 100 0 1.25 0 100 3.5 0 100 3.6 100 0 5 100 0 Immobilization of concanavalin A – Affinity chromatography 0 1 2 3 4 5 Time (min) Ribonuclease HRP

Chrombook (WEB-Version)

LORENZO Phone +595 (0) 21 522 322 Telefax +595 (0) 21 522 322 E-mail crizzi@lasca.com.py PERU Merck Peruana S.A. Av. Los Frutales No. 220 Ate LIMA 3 Phone +51 (0) 1 618 7500 Telefax +51 (0) 1 437 2955 E-mail

MultiScreen® and Millicell® Filter Plates for Assay Development

10%. * %CV = (SD/mean)*100. 1 2 3 4 A 599 601 649 605 B 509 649 631 598 C 584 607 609 618 D 619 550 605 625 C. Spot number by well location

Cytoskeletal Signaling Antibodies, Reagents and Kits

Rb 100 µL AB1965 WAVE Monoclonal Antibody Anti-WAVE1/Scar1 84.79 R WB Ascites M IgG 200 µL 05-618 Polyclonal Antibody Anti-WAVE/Scar H M R WB IP Pur Rb IgG 100 µg 07-037 Anti-WAVE2/Scar2 H

XP725 Antibody List 013M4793

_055232.1,NP_573497.1 P y y n/d 617 PUMA/bbc3, N-Terminal P4743 27113 BBC3 NP_055232.1 P y n/d n/d 618 Pyk2 P3902 50646, 2185, 19229 Ptk2b,PTK2B NP_059014.2,NP_775268.1,NP_766086.1 P y y y 619 phospho-Pyk2

XP725 Antibody List

_055232.1,NP_573497.1 P y y n/d 617 PUMA/bbc3, N-Terminal P4743 27113 BBC3 NP_055232.1 P y n/d n/d 618 Pyk2 P3902 50646, 2185, 19229 Ptk2b,PTK2B NP_059014.2,NP_775268.1,NP_766086.1 P y y y 619 phospho-Pyk2